Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium

NCT00034177 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Urologic Neoplasms

Interventions

DRUG: S-8184 Paclitaxel Injectable Emulsion
DRUG: Experimental Arm: TOCOSOL Paclitaxel

Sponsor

Achieve Life Sciences